-
Pertuzumab
- names:
Pertuzumab
- CAS号:
380610-27-5
MDL Number: - MF(分子式): MW(分子量): 145175.18
- EINECS: Reaxys Number:
- Pubchem ID: Brand:BIOFOUNT
| 货品编码 | 规格 | 纯度 | 价格 (¥) | 现价(¥) | 特价(¥) | 库存描述 | 数量 | 总计 (¥) |
|---|
| 中文别名 | |
| 英文别名 | Pertuzumab |
| CAS号 | 380610-27-5 |
| Inchi | |
| InchiKey | |
| 分子式 Formula | |
| 分子量 Molecular Weight | 145175.18 |
| 溶解度Solubility | |
| 性状 | |
| 储藏条件 Storage conditions | 请根据产品建议的存储条件进行存储,Please store the product under the recommended condition sin the description. |
| 产品说明 | |
| Introduction | Pertuzumab, a humanized monoclonal antibody, is aHER2dimerization inhibitor for the treatment of metastatic HER2-positive breast cancer. |
| Application1 | |
| Application2 | |
| Application3 |
Pertuzumab 是一种有效的人源化单克隆抗体,是一种有效的HER2二聚抑制剂。可用于治疗转移性HER2 阳性乳腺癌。Pertuzumab, a humanized monoclonal antibody, is aHER2dimerization inhibitor for the treatment of metastatic HER2-positive breast cancer.
| 【1】.Nahta R, et al. The HER-2-targeting antibodies trastuzumab and pertuzumab synergistically inhibit the survivalof breast cancer cells. Cancer Res. 2004 Apr 1;64(7):2343-6. |
| 【2】.Scheuer W, et al. Strongly enhanced antitumor activity of trastuzumab and pertuzumab combination treatment on HER2-positive human xenograft tumor models. Cancer Res. 2009 Dec 15;69(24):9330-6. |
对不起,暂无产品评价!
MSDS
SDS 1.0 中文
展开
SDS 1.0 英文
展开
- 相关产品
-
< >
- 推荐产品
-
< >
- 最新产品
-
< >
新闻
抱歉,暂无数据!


购物车 


